SAN DIEGO, Aug. 19, 2014 (GLOBE NEWSWIRE) -- SpectraScience, Inc. (OTCQB:SCIE) today announced the Company will hold a conference call at 4:30 p.m. Eastern (1:30 p.m. Pacific) on August 26, 2014 to provide an update on its business.
To access the call, please dial (877) 303-7908 and provide the Conference ID: 90530168. The conference call will also be broadcast live via the Internet and can be accessed through the "Investor Relations" page of the Company's website, www.spectrascience.com.
At the conclusion of the call, a replay will be available until September 1, 2014. To access the replay of the call dial (855) 859-2056 and provide the same Conference ID. A webcast archive will be available at www.spectrascience.com shortly after the call as well.
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. For more information, visit our web site www.spectrascience.com.
CONTACT: Media and Investors: SpectraScience, Inc., Lowell Giffhorn, CFO, Phone: (858) 847-0200 x2019 Email: email@example.comSource:SpectraScience, Inc.